Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2020
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLCKai Zhang, Xiaohua Hong, Zhengbo Song, et al.
NPJ Precision Oncology|December 12, 2025
A machine learning-based framework for prognostic prediction and tumor microenvironment characterization of locally advanced cervical cancer with concurrent chemoradiotherapyYue Feng, Zijian Sun, Yuqiang Li, et al.
Journal of Thoracic Disease|September 15, 2025
Inclusion of anti-vascular therapy as a promising option for later-line treatment of malignant pleural mesothelioma: a retrospective studyKeda Shao, Di Wu, Qian Wang, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2026
Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapyKübra Canaslan, Fatemeh Moeini Nia, Maria Baez, et al.
Therapeutic Advances in Medical Oncology|October 1, 2025
Epidemiology and clinical characteristics of mesothelioma in the Chinese population: a multicenter studyShengjie Yang, Yue Hao, Ke Wang, et al.
Nature Communications|June 12, 2023
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancerShen Zhao, Wu Zhuang, Baohui Han, et al.
Patterns (New York, N.Y.)|March 5, 2025
SplitFusion enables ultrasensitive gene fusion detection and reveals fusion variant-associated tumor heterogeneityWeiwei Bian, Baifeng Zhang, Zhengbo Song, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2019
Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 InhibitorsZhijie Wang, Jianchun Duan, Guoqiang Wang, et al.
BMC Cancer|December 16, 2023
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter studyXinlong Zheng, Longfeng Zhang, Lin Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 studyZhengbo Song, Ziming Li, Yiping Zhang, et al.
Pageof 15